CASE REPORT
An adolescent with isolated systolic hypertension – case report and diagnostic and therapeutic approach
1
Student Scientific Group at the Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland
2
Department of Pediatrics and Nephrology, Doctoral School, Medical University of Warsaw, Warsaw, Poland
3
Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland
Submission date: 2022-05-24
Final revision date: 2022-06-04
Acceptance date: 2022-06-05
Publication date: 2022-09-30
Pediatr Pol 2022;97(3):269-274
KEYWORDS
TOPICS
ABSTRACT
Primary hypertension (PH) is the most common cause of arterial hypertension in adolescents; many of these patients present with isolated systolic hypertension (ISH).
The study presents a case of a 16-year-old male adolescent with PH. The patient had ISH in both 24-hour-ambulatory and office measurements. Secondary causes and hypertension-mediated organ damage were excluded. Evaluation of the vascular phenotype revealed low central systolic blood pressure (109 mm Hg), high peripheral augmentation index (27 mm Hg), and high arterial elasticity. The boy was started on non-pharmacological treatment. The manuscript discusses up-to-date knowledge on the pathogenesis and evolution of ISH in young people. A diagnostic and therapeutic approach according to the European Society of Hypertension is presented.
Adolescents with ISH require evaluation of the vascular phenotype. There is a need for further studies on the evolution and long-term outcome in young people with this form of arterial hypertension.
The study presents a case of a 16-year-old male adolescent with PH. The patient had ISH in both 24-hour-ambulatory and office measurements. Secondary causes and hypertension-mediated organ damage were excluded. Evaluation of the vascular phenotype revealed low central systolic blood pressure (109 mm Hg), high peripheral augmentation index (27 mm Hg), and high arterial elasticity. The boy was started on non-pharmacological treatment. The manuscript discusses up-to-date knowledge on the pathogenesis and evolution of ISH in young people. A diagnostic and therapeutic approach according to the European Society of Hypertension is presented.
Adolescents with ISH require evaluation of the vascular phenotype. There is a need for further studies on the evolution and long-term outcome in young people with this form of arterial hypertension.
REFERENCES (23)
1.
Song P, Zhang Y, Yu J, et al. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr 2019; 173: 1154-1163.
2.
Wyszyńska T, Cichocka E, Wieteska-Klimczak A, et al. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 1992; 81: 244-246.
3.
Gupta-Malhotra M, Banker A, Shete S, et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens 2015; 28: 73-80.
4.
Litwin M, Feber J, Niemirska A, et al. Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities. Pediatr Nephrol 2016; 31: 185-194.
5.
Palatini P, Rosei EA, Avolio A, et al. Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension. J Hypertens 2018; 36: 1222-1236.
6.
Evans RG, Bie P. Role of the kidney in the pathogenesis of hypertension: time for a neo-Guytonian paradigm or a paradigm shift? Am J Physiol Regul Integr Comp Physiol 2016; 310: R217-229.
7.
Padmanabhan S, Dominiczak AF. Genomics of hypertension: the road to precision medicine. Nat Rev Cardiol 2021; 18: 235-250.
8.
Kułaga Z, Litwin M, Tkaczyk M, et al. Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr 2011; 170: 599-609.
9.
Reusz GS, Cseprekal O, Temmar M, et al. Reference values of pulse wave velocity in healthy children and teenagers. Hypertension 2010; 56: 217-224.
10.
Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34: 1887-1920.
11.
Doyon A, Kracht D, Bayazit AK, et al. Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension 2013; 62: 550-556.
12.
Tykarski A, Filipiak KJ, Januszewicz A, et al. Zasady postępowania w nadciśnieniu tętniczym — 2019 rok. Nadciśn Tetn Prakt 2019; 5: 1-86.
13.
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140: e20171904.
14.
Żurowska A, Zwolińska D, Roszkowska-Blaim M, et al. Rekomendacje Polskiego Towarzystwa Nefrologii Dziecięcej (PTNFD) dotyczące postępowania z dzieckiem z podwyższonym ciśnieniem tętniczym. Forum Med Rodz 2015; 9: 349-375.
15.
Litwin M, Kułaga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol 2021; 36: 825-837.
16.
Deja A, Skrzypczyk P, Nowak M, et al. Evaluation of active renin concentration in a cohort of adolescents with primary hypertension. Int J Environ Res Public Health 2022; 19: 5960.
17.
Sethi S, Rivera O, Oliveros R, et al. Aortic stiffness: pathophysiology, clinical implications, and approach to treatment. Integr Blood Press Control 2014; 7: 29-34.
18.
Litwin M, Obrycki Ł, Niemirska A, et al. Central systolic blood pressure and central pulse pressure predict left ventricular hypertrophy in hypertensive children. Pediatr Nephrol 2019; 34: 703-712.
19.
Elmenhorst J, Hulpke-Wette M, Barta C, et al. Percentiles for central blood pressure and pulse wave velocity in children and adolescents recorded with an oscillometric device. Atherosclerosis 2015; 238: 9-16.
20.
Obrycki Ł, Feber J, Brzezińska G, et al. Evolution of isolated systolic hypertension with normal central blood pressure in adolescents-prospective study. Pediatr Nephrol 2021; 36: 361-371.
21.
Sarnecki J, Obrycki Ł, Feber J, et al. Isolated systolic hypertension is associated with increased left ventricular mass index and aortic stiffness in adolescents: a cardiac magnetic resonance study. J Hypertens 2022; 40: 985-995.
22.
McEniery CM, Cockcroft JR, Roman MJ, et al. Central blood pressure: current evidence and clinical importance. Eur Heart J 2014; 35: 1719-1725.
23.
Borghi C, Acelajado MC, Gupta Y, et al. Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients. J Hum Hypertens 2017; 31: 605-610.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
